$Mcig VitaCig, Inc. Launches Two New Flavors: "Grace" and

New Post Public Reply Private Reply Replies (0) Message Board
MattySimone RobInvest #36500
$Mcig VitaCig, Inc. Launches Two New Flavors: "Grace" and "Calm" -- Raises VitaCig Price to $5 Each

BELLEVUE, Wash., Aug 01, 2014 (GLOBE NEWSWIRE via COMTEX) -- -- Nicotine-Free Tobacco-Free Smokeless Alternative to Traditional Cigarettes

-- Simply Vitamins + Natural Flavors Conveniently Vaporized by an eCig-like Device

-- VitaCig(R) Grace - The only eCig in the world containing Collagen

-- VitaCig(R) Calm - The only eCig in the world containing Valerian

mCig, Inc. (OTCQB:MCIG) is pleased to announce that its wholly owned subsidiary VitaCig, Inc. has officially launched two exciting new flavors: VitaCig(R) Calm and VitaCig(R) Grace targeting stress-reduction and skin rejuvenation. Additionally, the Company would like to announce that as of today the price VitaCig(R) will be increased to $5 each from $3 each. In light of the price increase, the Company has eliminated all shipping costs and order minimums for United States Domestic orders.

The VitaCig(R) is an innovative $5 device that is nicotine-free and smokeless. Instead of harmful toxins, the VitaCig(R) emits flavorful vapor comprised of vitamins, natural supplements, and organic flavors. The VitaCig(R) experience is unique and encompasses everything you love (or loved) about smoking without the things you don't. No tobacco smoke or cigarette smell. No more harmful tar, and no nicotine, just vitamins + flavored vapor delivered in a sleek metallic casing that looks and feels like an eCig.

The VitaCig(R) comes in five great flavor combinations: Calm, Energize, Grace, Refresh, and Relax. Order one today by visiting: http://www.VitaCig.org.

New Flavors - "Calm" and "Grace"

VitaCig(R) CALM

When you need to de-stress or enjoy a moment of serenity throughout the day try VitaCig "Calm" the only nicotine-free eCig with Valerian. Valerian is widely used around the world for relieving mild nervous tension and sleep disorders. Also known for antispasmodic properties, dysmenorrhoea, and menstrual cramping relief. It can be beneficial for relieving pain from migraine & rheumatic pain.

Flavors: Matcha green tea + vanilla bean and valerian, a natural herb that has been shown to reduce anxiety and assist with insomnia. Encased in a snow-white colored casing.

VitaCig(R) GRACE

Vaporized Skincare - the only nicotine-free eCig with Collagen, the most important structural protein in the human body. The degradation of collagen causes wrinkles and other skin issues. As a result, collagen is one of the most popular supplements due to its skin healing properties that are considered to be the "glue that holds the body together".

Flavors: Mint + light cherry and collagen. Encased in a shiny metallic gold casing.

Every VitaCig(R) includes the following base Vitamins A, B, C, E, and CoQ10.

"Today we announced our entrance into two new markets: Skincare, and stress-reduction. Collagen is the only protein which the body is unable to regenerate on its own. As women age, they need to supplement their collagen loss. Many women world-wide take collagen pills on a daily basis and the industry is one of the fastest growing in the nutritional supplement space. Unlike the other VitaCigs, we chose to encase "Grace" in a sleek and shiny metallic gold, appealing to women as an accessory item like lipstick. We are very excited about VitaCig "Grace" and believe it has the potential to become category-killer. VitaCig "Calm" was perfected over nearly two months of rigorous testing. The natural matcha green tea extract coupled with vanilla-bean produces an incredibly soothing and satisfying flavor that we hope will become synonymous with our brand. This calming flavor is coupled with the delivery of valerian extract, one of the most impressive compounds in the world that has shown in multiple studies to significantly reduce stress levels," said Mark Linkhorst, CEO of VitaCig, Inc.

"When we launched VitaCig, we had no idea how much this product would positively affect the lives of our customers. Since launching only three months ago, we have listened to our customers and have innovated accordingly. The more customers use the product, the quicker they realize that VitaCig(R) is nothing like a traditional electronic cigarette. While it appears to satisfy ones urge to quit smoking traditional nicotine cigarettes, it more closely resembles chewing gum in terms of a consumer product. In other words, there are a multitude of additional applications we can address with this technology while mitigating the urge to smoke. As we have always stated, we see mobile vaporization technology as a unique opportunity to more efficiently deliver compounds/nutrients into the human body," said Paul Rosenberg, CEO of mCig, Inc. the parent of VitaCig, Inc.

VitaCig, Inc. Dividend and IPO Update

On July 29, 2014, The Company received its fourth round of comments from the Securities and Exchange Commission relating to the VitaCig, Inc. S1. In total the company received 9 comments, down from 19 the previous round, and 42 in the initial round. The company is preparing to file what it hopes will be the final S1/A in the next 10 days. The company reminds shareholders that the effective date for the VitaCig, Inc. spin-off and pro-rata dividend of (1) share of VitaCig, Inc. for every (1) share of mCig, Inc. will be the date the prospectus (S1/A) is declared effective by the SEC.

About VitaCig, Inc.

VitaCig, Inc. is a technology company that is harnessing mobile vaporization technology for medical delivery applications. The company has launched its first consumer product: The VitaCig, a $5 nicotine-free device that looks and feels like an electronic cigarette (eCig). Unlike a traditional eCig, the VitaCig delivers a vapor of natural flavors, vitamins, and phytonutrients. The company is currently a subsidiary of mCig, Inc. (Stock Symbol: MCIG) that is in the process of being spun-off to shareholders.

The traditional tobacco industry is estimated at nearly $900 Billion a year. Financial analysts from Wells Fargo, Goldman Sachs, and Citigroup predict that by 2022 Electronic Cigarettes will supplant the traditional tobacco industry and eventually grow into a $1 Trillion industry.

VitaCig is disrupting both the traditional tobacco industry and the growing electronic cigarette industry by appealing to the existing 1.2 Billion adults globally that smoke cigarettes, providing them with a nicotine and tobacco-free alternative that may assist in harm reduction. Moreover, the company is expanding the target market beyond the 1.2 Billion adults by appealing to non-smokers or occasional smokers with a superior method for the consumption of Vitamins, Nutrients, and other compounds with medicinal efficacy. - To learn more visit: http://www.vitacig.org/investors/investor-opp...y-subpage/.

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.

CONTACT: Paul Rosenberg
CEO
(425) 462-4219

http://www.globenewswire.com/newsroom/ti?nf=M...gjMjg2MTM=

(C) Copyright 2014 GlobeNewswire, Inc. All rights reserved.

-0-

KEYWORD: BELLEVUE, Wash.
INDUSTRY KEYWORD: Consumer Services
SUBJECT CODE: Product / Services Announcement
PRODUCT
I own shares of the stock I post about and I may or may not buy or sell those shares without notification
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 1

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 2

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 2

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 2

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 2

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 3

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 3

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 5

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 2

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading

Top 5 Most Recently Viewed Articles

Justin Thompson Takes Charge as VP of IT Data and Analytics

Updated Category News Views 486

JetBlue's New Leadership in Data and Analytics JetBlue has announced a significant promotion within its ranks by naming Justin Thompson as Vice President of IT Data and Analytics. This strategic appointment highlights JetBlue's commitment to leveraging data as a core component of its operational and growth strategies. Role and Responsibilities of Justin Thompson In his...

Continue Reading
Navigating Growth in the Ultrafine Pulverizer Market Landscape

Updated Category News Views 153

Understanding the Ultrafine Pulverizer Market The global ultrafine pulverizer market is currently valued at approximately USD 1.2 billion, with immense growth predicted over the next decade. As we look ahead to the year 2034, the market is anticipated to swell to USD 2.5 billion, exhibiting a robust Compound Annual Growth Rate (CAGR) of about 7.6% from 2025 to 2034. This...

Continue Reading
Fosun's Commitment to Global Health Through Innovation

Updated Category News Views 181

Fosun's Global Innovation Strategy Guo Guangchang, Chairman of Fosun International, has recently emphasized the importance of globalization and innovation at a biopharmaceutical conference. Underlining that the future of the pharmaceutical industry lies in original innovation and open cooperation, he reinforced Fosun's commitment to integrating global advancement...

Continue Reading
Investors Beware: Is Beta Bionics (NASDAQ: BBNX) in Trouble?

Updated Category News Views 305

The Deep Dive into Beta Bionics (NASDAQ: BBNX) Here we are again, folks. Hearing rumblings about Beta Bionics, and I can't help but feel a slight knot in my stomach. Just when you think the market's gotta settle down, it throws a curveball, and right now, it looks like Beta Bionics is in murky waters courtesy of potential legal troubles. I mean, when litigation starts...

Continue Reading
Noah Holdings Reports Strong Q1 2025 Earnings and Growth Trends

Updated Category News Views 161

Noah Holdings Reports Strong Q1 2025 Earnings and Growth Trends Noah Holdings Limited (NYSE: NOAH), a prominent player in wealth management services, reported impressive financial results for the first quarter of 2025, demonstrating notable year-on-year (YoY) and sequential growth in profitability. The company, known for its tailored advisory services aimed at...

Continue Reading